VCI Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,636
Closed -$2.47M – 118
2026
Q2
$2.47M Buy
11,636
+2,974
+34% +$584K 0.62% 44
2026
Q1
$1.7M Sell
8,662
-761
-8% -$148K 0.47% 44
2025
Q4
$1.64M Buy
+9,423
New +$1.72M 0.45% 55

Other funds holding DGX

VCI Wealth Management's DGX Position: Q3 2026 in Review

VCI Wealth Management sold out of Quest Diagnostics (DGX) in Q3 2026, closing a stake of 11,636 shares — an estimated $2.47M sold.

VCI Wealth Management first reported a position in DGX in Q4 2025 and held it in 3 quarters. The position peaked at $2.47M in Q2 2026. 1,139 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • VCI Wealth Management reported no remaining Quest Diagnostics position as of Q3 2026 after selling out during the quarter.
  • VCI Wealth Management sold 11,636 Quest Diagnostics shares in Q3 2026, an estimated $2.47M.
  • VCI Wealth Management first reported a position in Quest Diagnostics in Q4 2025 and held it in 3 quarters.
  • VCI Wealth Management's Quest Diagnostics position peaked at $2.47M in Q2 2026.
  • 1,139 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on VCI Wealth Management's 13F filing for Q3 2026, filed 29 Oct 2026.